Moderna, Inc. (MRNA)

SEC filing

Moderna, Inc.

MRNA · CIK 1682852

4 · Sep 3, 2026 · Chief Legal Officer Klinger Shannon Thyme sold 3,471 shares at $139.95/share ($485.8K); exercised options for 11.27K shares; reported 1,048 shares

Chief Legal Officer Klinger Shannon Thyme sold 3,471 shares at $139.95/share ($485.8K); exercised options for 11.27K shares; reported 1,048 shares

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001682852-26-000167
Filer: Moderna, Inc.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTform4.xml
Open SEC.gov